In summary, our results provide evidence that GP73 can activate the TGF‐β1/Smad2 signalling pathway and induce the EMT via down‐regulating WT1 expression, thereby promoting the invasion and metastasis of bladder cancer. Here, SMAD2 is linked to urinary bladder carcinoma.